Chang J W, Yeow R Y, Waljee A K, Rubenstein J H
Division of Gastroenterology, Department of Internal Medicine.
Department of Internal Medicine, University of Michigan.
Dis Esophagus. 2018 Aug 1;31(8). doi: 10.1093/dote/doy049.
Treatment endpoints in eosinophilic esophagitis (EoE) are response of eosinophilic inflammation and of symptoms. Steroids and diet therapy are effective in inducing histologic response in EoE, but there may be poor correlation between histologic and symptomatic response. Despite this, we find that in clinical practice symptoms are commonly used to guide management without assessing histologic response. We hypothesized that symptom response alone is not reliable in assessing response to therapy and is confounded by endoscopic dilation. We conducted a systematic review and meta-regressions to estimate the association of histologic and symptomatic response, stratified by whether concurrent dilation was permitted. We performed a systematic search of PubMed, EMBASE, and Web of Science for studies describing both histologic and symptomatic responses to dilation, steroid, and diet therapies. We abstracted the proportion of histologic response and symptom response. Studies were stratified by whether dilation was permitted. We performed meta-regressions of the association between the proportions with histologic and symptomatic response, stratified by whether dilation was permitted. We identified 1359 articles, of which 62 articles were assessed for eligibility, and 23 were included providing data on 1202 patients with EoE. Unstratified meta-regression of histologic versus symptomatic response showed moderate association and large heterogeneity (inconsistency index [I2] = 89%). In adult studies in which dilation was allowed, there was weak association between symptomatic and histologic response (β1 = 0.21), minimal symptomatic response of 67% and the heterogeneity persisted, I2 = 77%. In studies that prohibited dilation, maximal symptomatic response was 72% and was moderately associated with histologic response (β1 = 0.39) with less heterogeneity, I2 = 59%. Studies of EoE that permit dilation obscure the relation between histologic and symptomatic response and have a high floor effect for symptomatic response. Studies that prohibit dilation demonstrate moderate association between histologic and symptomatic response, but have a ceiling effect for symptomatic response. Our results demonstrate that success of dietary or medical management for EoE cannot be judged by symptoms alone, and require histologic assessment, particularly if dilation has been performed.
嗜酸性食管炎(EoE)的治疗终点是嗜酸性炎症反应和症状反应。类固醇和饮食疗法在诱导EoE的组织学反应方面有效,但组织学反应和症状反应之间可能相关性较差。尽管如此,我们发现在临床实践中,症状通常被用来指导治疗,而不评估组织学反应。我们推测,仅症状反应在评估治疗反应时不可靠,并且会受到内镜扩张的干扰。我们进行了一项系统评价和meta回归分析,以估计组织学反应和症状反应之间的关联,并根据是否允许同时进行扩张进行分层。我们对PubMed、EMBASE和科学网进行了系统检索,以查找描述扩张、类固醇和饮食疗法的组织学和症状反应的研究。我们提取了组织学反应和症状反应的比例。研究根据是否允许扩张进行分层。我们对组织学反应和症状反应比例之间的关联进行了meta回归分析,并根据是否允许扩张进行分层。我们识别出1359篇文章,其中62篇文章进行了资格评估,23篇文章被纳入,提供了1202例EoE患者的数据。组织学反应与症状反应的未分层meta回归分析显示出中度关联和较大异质性(不一致指数[I2]=89%)。在允许扩张的成人研究中,症状反应与组织学反应之间的关联较弱(β1=0.21),最小症状反应为67%,异质性仍然存在,I2=77%。在禁止扩张的研究中,最大症状反应为72%,与组织学反应中度相关(β1=0.39),异质性较小,I2=59%。允许扩张的EoE研究掩盖了组织学反应和症状反应之间的关系,并且症状反应有较高的最低效应。禁止扩张的研究表明组织学反应和症状反应之间存在中度关联,但症状反应有最高效应。我们的结果表明,EoE饮食或药物治疗的成功不能仅通过症状来判断,还需要组织学评估,特别是在进行了扩张的情况下。